Etiopathogenetic principles and peptic ulcer disease classification

Digestive Diseases

Volumn 29, Issue 5, 2011, Pages 454-458

  Tytgat, G N J ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NONE   (Netherlands)

Author keywords

Healthy gastroduodenal mucosa; Peptic ulcer disease classification; Peptic ulceration

Indexed keywords

ACETYLSALICYLIC ACID; BISMUTH; HISTAMINE H2 RECEPTOR ANTAGONIST; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; TETRACYCLINE;

ARTICLE; DISEASE CLASSIFICATION; DUODENUM ULCER; GASTRECTOMY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; PEPTIC ULCER; PRIORITY JOURNAL; SMOKING; STOMACH ACID; STOMACH PH; STOMACH ULCER; VAGOTOMY;

EID: 81755171145     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000331520     Document Type: Article

References (2)

1. Rauws E AJ, Ty tgat GNJ: Cure of duoden a l u l-cer associated with eradication of Helico-bacter pylori. Lancet 1990;335: 1233-1235. (Pubitemid 20181778)
2. Scarpignato C, Hunt RH: Nonsteroidal anti-inf lammatory drug-related injury to the gastrointestinal tract: clinical picture, patho-genesis, and prevention. Gastroenterol Clin North Am 2010;39: 433-464.